| 发明名称 |
VEGF ANTAGONISTS FOR THE TREATMENT OF DIABETES |
| 摘要 |
Methods of treating diabetes in mammals, particularly humans, by blocking or inhibiting VEGF-mediated activity. A preferred inhibitor of VEGF-mediated activity is a VEGF antagonist such as a VEGF trap capable of binding and blocking VEGF. |
| 申请公布号 |
PT1608685(E) |
申请公布日期 |
2007.05.31 |
| 申请号 |
PT20040758372T |
申请日期 |
2004.03.26 |
| 申请人 |
REGENERON PHARMACEUTICALS, INC. |
发明人 |
MARK W. SLEEMAN;STANLEY J. WIEGAND |
| 分类号 |
C07K19/00;A61K31/7088;A61K38/17;A61P3/10;C07K14/52;C07K14/71;C07K16/28 |
主分类号 |
C07K19/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
